Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

Cited by (518)

Items 501–518 of 518

1. Tau Protein in Alzheimer's Disease
   Maitreyee Mukherjee, Soumen Dhara, Abhishek Jana, Tathagata Roy · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
2. Metal Binding to Tau Protein: Physiological and Pathological Relevance
   Liliana Quintanar, Gerardo U. Juarez-Romero, Gala R. Lopez-Herrera · 2026 · Biochemistry
3. Tau-mediated Mechanisms in Alzheimerʼs Disease Pathogenesis
   Tanu Suma Narayanappa, Vaishnavi Ananthanarayana, Subashchandrabose Chinnathambi · 2026 · Molecular Neurobiology
4. Is Tau Acetylation a Key to Frontotemporal Lobar Degeneration Diagnosis?
   Diana Piotrowska, Irena Matečko‐Burmann, Laia Montoliu‐Gaya, Gunnar Brinkmalm, Henrik Zetterberg · 2026 · Clinical Chemistry
5. Modifications of Lysine Residues 294 and 311 Within the Microtubule‐Binding Region Alter Tau Aggregation and Tubulin Binding Equilibria
   Dominik P. Vogl, Mario Migotti, Robert Konrat, Anne C. Conibear, Christian F. W. Becker · 2026 · Angewandte Chemie
6. Modifications of Lysine Residues 294 and 311 Within the Microtubule‐Binding Region Alter Tau Aggregation and Tubulin Binding Equilibria
   Dominik P. Vogl, Mario Migotti, Robert Konrat, Anne C. Conibear, Christian F. W. Becker · 2026 · Angewandte Chemie International Edition
7. Therapeutic targeting of tauopathies: From druggable biology to precision intervention
   Chengjia Zhang, Jialiang Ma, Xinruo Wu, Xingyi Wang, Xiaohua Huang, Honghua Zheng, Yingjun Zhao · 2026 · Pharmacological Research
8. SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential
   Jiabin Duan, Jiaqi Liu, Qingsheng Meng, Jiahao Liu, Sitian Yang, Fang Zhou, Jing Cao · 2026 · The FASEB Journal
9. Alcohol-induced dysregulation of tau and acetylation pathways in the pathogenesis of Alzheimer’s disease
   KC Basavaraju, Harshitha D K, Poornima Priyadarshini C. G. · 2026 · Neuroscience
10. PROTAC as a Potential Toolbox for the Discovery of New Targets and Drugs
    Mengjun Ma, Xiaolei Meng, Chong Qin · 2026 · Handbook of experimental pharmacology
11. Rethinking tau‐targeted therapy in Alzheimer's disease: Toward a dual biomarker strategy
    Charlotte Elisabeth Teunissen, Lorenzo Pini, Bruno Pietro Imbimbo · 2026 · Alzheimer s & Dementia
12. Protein damage and repair in aging: Mechanisms, homeostasis and disease
    Alex Lyakhovich, Luigi Ferrucci · 2026 · Ageing Research Reviews
13. Targeting tau acetylation in Alzheimer's disease: Molecular mechanisms, pathological consequences, and therapeutic opportunities of dietary phytochemicals
    Basavaraju KC, Poornima Priyadarshini C. G. · 2026 · Biochemical and Biophysical Research Communications
14. Mapping the Landscape of Tau Post-translational Modifications and Kinase-Specific Phosphorylation Signatures by Orthogonal CZE-MS/MS and NanoRPLC-MS/MS
    Reyhane Tabatabaeian Nimavard, Seyed Amirhossein Sadeghi, Jorge A. Colón-Rosado, Yifan Yue, Fei Fang, Hsiao‐Tien Chien Hagar, Min-Hao Kuo, Liangliang Sun · 2026 · Journal of Proteome Research
15. BindingDB Entry 50016393: Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.
    BindingDB · 2023 · UC San Diego
16. BindingDB Entry 50010784: Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor.
    BindingDB · 2021 · UC San Diego
17. BindingDB Entry 50021669: Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges.
    BindingDB · 2025 · UC San Diego
18. Histone Modifications at the Intersection of Aging, Neuroinflammation and Metabolism in Alzheimer's Disease
    Junyi Liang, Huawen Cao, 任秀敏, Nan Sha, Xueqing Han, Ling Jiang, Bin Liu, Weiming Zhao · 2026 · Aging Cell